1. Home
  2. BMRA vs YCBD Comparison

BMRA vs YCBD Comparison

Compare BMRA & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • YCBD
  • Stock Information
  • Founded
  • BMRA 1971
  • YCBD 2015
  • Country
  • BMRA United States
  • YCBD United States
  • Employees
  • BMRA N/A
  • YCBD N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • YCBD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRA Health Care
  • YCBD Health Care
  • Exchange
  • BMRA Nasdaq
  • YCBD Nasdaq
  • Market Cap
  • BMRA 8.1M
  • YCBD 7.8M
  • IPO Year
  • BMRA N/A
  • YCBD N/A
  • Fundamental
  • Price
  • BMRA $3.91
  • YCBD $0.95
  • Analyst Decision
  • BMRA
  • YCBD Strong Buy
  • Analyst Count
  • BMRA 0
  • YCBD 1
  • Target Price
  • BMRA N/A
  • YCBD $3.00
  • AVG Volume (30 Days)
  • BMRA 95.1K
  • YCBD 67.8K
  • Earning Date
  • BMRA 08-27-2025
  • YCBD 08-13-2025
  • Dividend Yield
  • BMRA N/A
  • YCBD N/A
  • EPS Growth
  • BMRA N/A
  • YCBD N/A
  • EPS
  • BMRA N/A
  • YCBD N/A
  • Revenue
  • BMRA $5,678,000.00
  • YCBD $19,593,146.00
  • Revenue This Year
  • BMRA N/A
  • YCBD $13.00
  • Revenue Next Year
  • BMRA N/A
  • YCBD $10.00
  • P/E Ratio
  • BMRA N/A
  • YCBD N/A
  • Revenue Growth
  • BMRA 5.01
  • YCBD N/A
  • 52 Week Low
  • BMRA $1.93
  • YCBD $0.76
  • 52 Week High
  • BMRA $10.16
  • YCBD $6.54
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 63.63
  • YCBD 51.65
  • Support Level
  • BMRA $3.50
  • YCBD $0.90
  • Resistance Level
  • BMRA $4.24
  • YCBD $0.99
  • Average True Range (ATR)
  • BMRA 0.25
  • YCBD 0.06
  • MACD
  • BMRA 0.09
  • YCBD 0.01
  • Stochastic Oscillator
  • BMRA 74.62
  • YCBD 58.90

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: